Chikungunya: vision of the pain clinician

Detalhes bibliográficos
Autor(a) principal: Castro,Anita Perpetua Carvalho Rocha de
Data de Publicação: 2016
Outros Autores: Lima,Rafaela Araújo, Nascimento,Jedson dos Santos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista Dor
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132016000400299
Resumo: ABSTRACT BACKGROUND AND OBJECTIVES: Chikungunya is a viral disease of tropical distribution which affects individuals in different countries of the world and is associated to variable clinical presentations, characterized by the existence of two phases: acute and chronic. The acute phase is short-lasting with nonspecific symptoms. The chronic phase is marked by persistent pain, impairing patients' quality of life. This study aimed at discussing Chikungunya, from the pain clinician point of view, paying attention to its epidemiological, pathophysiological, diagnostic and therapeutic aspects, especially with regard to pain management. CONTENTS: Chikyngunya's pathophysiology is poorly understood and involves predominantly peripheral mechanisms. It is diagnosed by observation of suggestive clinical presentation associated to specific laboratory exams. Management of patients with confirmed diagnosis involves common analgesics and anti-inflammatory drugs, in addition to steroids, antidepressants and anticonvulsants for refractory cases. Patients with chronic inflammatory rheumatic disease seem to benefit from methotrexate. CONCLUSION: Chikungunya is a complex and still poorly understood entity. There are different therapeutic schemes to treat pain associated to it, however 40% of patients evolve with chronic pain and impairment of quality of life.
id SBED-1_4c4db538ab81210784be6db6e8a44bf6
oai_identifier_str oai:scielo:S1806-00132016000400299
network_acronym_str SBED-1
network_name_str Revista Dor
repository_id_str
spelling Chikungunya: vision of the pain clinicianArthralgiaChronic chikungunyaFeverPainABSTRACT BACKGROUND AND OBJECTIVES: Chikungunya is a viral disease of tropical distribution which affects individuals in different countries of the world and is associated to variable clinical presentations, characterized by the existence of two phases: acute and chronic. The acute phase is short-lasting with nonspecific symptoms. The chronic phase is marked by persistent pain, impairing patients' quality of life. This study aimed at discussing Chikungunya, from the pain clinician point of view, paying attention to its epidemiological, pathophysiological, diagnostic and therapeutic aspects, especially with regard to pain management. CONTENTS: Chikyngunya's pathophysiology is poorly understood and involves predominantly peripheral mechanisms. It is diagnosed by observation of suggestive clinical presentation associated to specific laboratory exams. Management of patients with confirmed diagnosis involves common analgesics and anti-inflammatory drugs, in addition to steroids, antidepressants and anticonvulsants for refractory cases. Patients with chronic inflammatory rheumatic disease seem to benefit from methotrexate. CONCLUSION: Chikungunya is a complex and still poorly understood entity. There are different therapeutic schemes to treat pain associated to it, however 40% of patients evolve with chronic pain and impairment of quality of life.Sociedade Brasileira para o Estudo da Dor2016-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132016000400299Revista Dor v.17 n.4 2016reponame:Revista Dorinstname:Sociedade Brasileira para o Estudo da Dor (SBED)instacron:SBED10.5935/1806-0013.20160093info:eu-repo/semantics/openAccessCastro,Anita Perpetua Carvalho Rocha deLima,Rafaela AraújoNascimento,Jedson dos Santoseng2017-01-03T00:00:00Zoai:scielo:S1806-00132016000400299Revistahttps://www.scielo.br/j/rdor/ONGhttps://old.scielo.br/oai/scielo-oai.phpdor@dor.org.br||dor@dor.org.br2317-63931806-0013opendoar:2017-01-03T00:00Revista Dor - Sociedade Brasileira para o Estudo da Dor (SBED)false
dc.title.none.fl_str_mv Chikungunya: vision of the pain clinician
title Chikungunya: vision of the pain clinician
spellingShingle Chikungunya: vision of the pain clinician
Castro,Anita Perpetua Carvalho Rocha de
Arthralgia
Chronic chikungunya
Fever
Pain
title_short Chikungunya: vision of the pain clinician
title_full Chikungunya: vision of the pain clinician
title_fullStr Chikungunya: vision of the pain clinician
title_full_unstemmed Chikungunya: vision of the pain clinician
title_sort Chikungunya: vision of the pain clinician
author Castro,Anita Perpetua Carvalho Rocha de
author_facet Castro,Anita Perpetua Carvalho Rocha de
Lima,Rafaela Araújo
Nascimento,Jedson dos Santos
author_role author
author2 Lima,Rafaela Araújo
Nascimento,Jedson dos Santos
author2_role author
author
dc.contributor.author.fl_str_mv Castro,Anita Perpetua Carvalho Rocha de
Lima,Rafaela Araújo
Nascimento,Jedson dos Santos
dc.subject.por.fl_str_mv Arthralgia
Chronic chikungunya
Fever
Pain
topic Arthralgia
Chronic chikungunya
Fever
Pain
description ABSTRACT BACKGROUND AND OBJECTIVES: Chikungunya is a viral disease of tropical distribution which affects individuals in different countries of the world and is associated to variable clinical presentations, characterized by the existence of two phases: acute and chronic. The acute phase is short-lasting with nonspecific symptoms. The chronic phase is marked by persistent pain, impairing patients' quality of life. This study aimed at discussing Chikungunya, from the pain clinician point of view, paying attention to its epidemiological, pathophysiological, diagnostic and therapeutic aspects, especially with regard to pain management. CONTENTS: Chikyngunya's pathophysiology is poorly understood and involves predominantly peripheral mechanisms. It is diagnosed by observation of suggestive clinical presentation associated to specific laboratory exams. Management of patients with confirmed diagnosis involves common analgesics and anti-inflammatory drugs, in addition to steroids, antidepressants and anticonvulsants for refractory cases. Patients with chronic inflammatory rheumatic disease seem to benefit from methotrexate. CONCLUSION: Chikungunya is a complex and still poorly understood entity. There are different therapeutic schemes to treat pain associated to it, however 40% of patients evolve with chronic pain and impairment of quality of life.
publishDate 2016
dc.date.none.fl_str_mv 2016-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132016000400299
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132016000400299
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5935/1806-0013.20160093
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira para o Estudo da Dor
publisher.none.fl_str_mv Sociedade Brasileira para o Estudo da Dor
dc.source.none.fl_str_mv Revista Dor v.17 n.4 2016
reponame:Revista Dor
instname:Sociedade Brasileira para o Estudo da Dor (SBED)
instacron:SBED
instname_str Sociedade Brasileira para o Estudo da Dor (SBED)
instacron_str SBED
institution SBED
reponame_str Revista Dor
collection Revista Dor
repository.name.fl_str_mv Revista Dor - Sociedade Brasileira para o Estudo da Dor (SBED)
repository.mail.fl_str_mv dor@dor.org.br||dor@dor.org.br
_version_ 1752126255451340800